Regulatory Resources
Clinical guidelines, MDCG guidance, FDA guidance, standards, and compliance tools
Safety and Performance Based Pathway
Final FDA guidance on 510(k). Published 2019 by CDRH/CBER.
Download PDFAnnual Reports for Approved Premarket Approval Applications (PMA)
Final FDA guidance on pma. Published 2019 by CDRH/CBER.
Download PDFAcceptance and Filing Reviews for Premarket Approval Applications (PMAs)
Final FDA guidance on pma. Published 2019 by CDRH/CBER.
Download PDF30-Day Notices, 135-Day PMA Supplements and 75-Day HDE Supplements for Manufacturing Changes
Final FDA guidance on pma. Published 2019 by CDRH/CBER.
Download PDFRecommended Content and Format of Non-Clinical Bench Performance Testing Information in Premarket Submissions
Final FDA guidance on testing & performance. Published 2019 by CDRH/CBER.
Download PDFRecommendations for CLIA Waiver Applications for In Vitro Diagnostic Devices
Final FDA guidance on ivd & diagnostics. Published 2020 by CDRH/CBER.
Download PDFNonbinding Feedback After Certain FDA Inspections of Device Establishments
Final FDA guidance on inspections. Published 2020 by CDRH/CBER.
Download PDFDeveloping and Labeling In Vitro Companion Diagnostic Devices for Oncology Therapeutic Products
Final FDA guidance on ivd & diagnostics. Published 2020 by CDRH/CBER.
Download PDFReview and Update of Device Establishment Inspection Processes and Standards
Final FDA guidance on inspections. Published 2020 by CDRH/CBER.
Download PDFProviding Regulatory Submissions for Medical Devices in Electronic Format — Section 745A(b)
Final FDA guidance on submission process. Published 2020 by CDRH/CBER.
Download PDF